The United Kingdom’s average life expectancy has increased from 71 to 81 years since 1960.
The increase is largely a result of medicinal and technological advances, particularly the tackling of childhood killers such as polio and measles.
Living standards, more nutritious diets and the quality of drinking water also contribute to this increase, and there is no evidence to suggest that it is slowing down with a predicted 1000% increase of people living beyond 100 years expected by 2050.
Technology has played a key role in this success and through future advancements connected health promises to further increase life expectancy.
Savings and cost reductions
One of the major benefits of connected health is its potential to streamline the public health system and free up medical staff to focus on those patients who need them most.
By making efficiencies and reducing healthcare costs connected health is predicted to save billions of pounds globally.
Surveillance has a number of uses in the connected health sector, first for individuals and secondly on a large scale. At an individual level, some diabetes sufferers now have access to technology that automatically tests blood sugar levels and reports them back to healthcare providers. Regular monitoring allows doctors to immediately see any sudden or long term changes that could pose a risk to the patient.
On a global scale, connected health systems are now able to trace the frequency and location of infectious diseases. This monitoring allows governments to stem the spread of diseases, preventing epidemics and saving lives.
While connected health has proven to have great value in monitoring diseases, we have yet to exploit its potential to save lives via preventative care.
It has been proposed that connected health technology could be used to collect data that may predict the onset of chronic illnesses and enable health practitioners to delay their onset or indeed prevent them entirely. While still in its infancy, mobile apps and other consumer technology may make this process a part of daily life in the future.
Lava Group is doing its part to help those with dementia and autism to receive the best support by developing a non-obtrusive system to provide long-term assessment of the environment and physiological metrics of dementia and autism patients within the home or residential care environment.
The Lava Group, working as part of a consortium, has secured £100,000 of funding from the Connected Health Innovation Centre (CHIC) to invest in R&D for its latest piece of behavioural analysis technology.
For more details on this project click here.